Key Financial Data Of Group

Chiome Bioscience Inc. - Filing #7312329

Concept As at
2024-06-30
2024-01-01 to
2024-06-30
2023-01-01 to
2023-12-31
As at
2023-12-31
As at
2023-06-30
2023-01-01 to
2023-06-30
Key financial data of group
Business results of group
Net sales
263,728,000 JPY
682,464,000 JPY
358,889,000 JPY
Ordinary profit (loss)
-563,345,000 JPY
-1,217,240,000 JPY
-662,139,000 JPY
Net assets
1,070,531,000 JPY
1,157,723,000 JPY
1,144,629,000 JPY
Total assets
1,557,439,000 JPY
1,751,454,000 JPY
1,685,551,000 JPY
Basic earnings (loss) per share
-10.21
-24.62
-13.70
Diluted earnings per share
Equity-to-asset ratio
0.680 xbrli:pure
0.651 xbrli:pure
0.672 xbrli:pure
Net cash provided by (used in) operating activities
-677,388,000 JPY
-1,069,192,000 JPY
-595,281,000 JPY
Net cash provided by (used in) investing activities
JPY
173,000 JPY
82,000 JPY
Net cash provided by (used in) financing activities
455,490,000 JPY
667,303,000 JPY
113,359,000 JPY
Cash and cash equivalents
1,103,656,000 JPY
1,325,554,000 JPY
1,245,431,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.